StonvexLoading…
StonvexCore line items from CNQ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | C$38.76B | C$35.66B | C$35.97B | C$42.30B |
Operating Income | C$13.24B | C$8.06B | C$10.16B | C$13.70B |
Net Income | C$10.82B | C$6.11B | C$8.23B | C$10.94B |
EPS (Diluted) | C$5.16 | C$2.85 | C$3.74 | C$4.76 |
Total Assets | C$91.83B | C$85.36B | C$75.95B | C$76.14B |
Total Liabilities | C$47.46B | C$45.89B | C$36.12B | C$37.97B |
Cash & Equivalents | C$673.00M | C$131.00M | C$877.00M | C$920.00M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | Not available | Not available | Not available |